1. Home
  2. SWKH vs SXTC Comparison

SWKH vs SXTC Comparison

Compare SWKH & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWKH
  • SXTC
  • Stock Information
  • Founded
  • SWKH 1996
  • SXTC 2005
  • Country
  • SWKH United States
  • SXTC China
  • Employees
  • SWKH N/A
  • SXTC N/A
  • Industry
  • SWKH Diversified Financial Services
  • SXTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • SWKH Finance
  • SXTC Health Care
  • Exchange
  • SWKH Nasdaq
  • SXTC Nasdaq
  • Market Cap
  • SWKH 175.5M
  • SXTC 184.5M
  • IPO Year
  • SWKH 1999
  • SXTC 2019
  • Fundamental
  • Price
  • SWKH $16.90
  • SXTC $1.32
  • Analyst Decision
  • SWKH Strong Buy
  • SXTC
  • Analyst Count
  • SWKH 1
  • SXTC 0
  • Target Price
  • SWKH $18.00
  • SXTC N/A
  • AVG Volume (30 Days)
  • SWKH 19.8K
  • SXTC 143.8K
  • Earning Date
  • SWKH 11-06-2025
  • SXTC 08-19-2019
  • Dividend Yield
  • SWKH N/A
  • SXTC N/A
  • EPS Growth
  • SWKH 120.89
  • SXTC N/A
  • EPS
  • SWKH 1.85
  • SXTC N/A
  • Revenue
  • SWKH $40,149,000.00
  • SXTC $1,740,907.00
  • Revenue This Year
  • SWKH $52.93
  • SXTC N/A
  • Revenue Next Year
  • SWKH N/A
  • SXTC N/A
  • P/E Ratio
  • SWKH $9.06
  • SXTC N/A
  • Revenue Growth
  • SWKH 62.38
  • SXTC N/A
  • 52 Week Low
  • SWKH $12.00
  • SXTC $0.95
  • 52 Week High
  • SWKH $17.90
  • SXTC $7.84
  • Technical
  • Relative Strength Index (RSI)
  • SWKH 60.11
  • SXTC 42.27
  • Support Level
  • SWKH $16.68
  • SXTC $1.32
  • Resistance Level
  • SWKH $17.00
  • SXTC $1.45
  • Average True Range (ATR)
  • SWKH 0.27
  • SXTC 0.10
  • MACD
  • SWKH -0.00
  • SXTC -0.00
  • Stochastic Oscillator
  • SWKH 58.88
  • SXTC 2.13

About SWKH SWK Holdings Corporation

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

About SXTC China SXT Pharmaceuticals Inc.

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

Share on Social Networks: